318 related articles for article (PubMed ID: 36933003)
21. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
22. Maternal serum biomarkers of placental insufficiency at 24-28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study.
Rahman S; Islam MS; Roy AK; Hasan T; Chowdhury NH; Ahmed S; Raqib R; Baqui AH; Khanam R
BMC Pregnancy Childbirth; 2024 Jun; 24(1):418. PubMed ID: 38858611
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
24. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
25. Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection.
Giardini V; Ornaghi S; Gambacorti-Passerini C; Casati M; Carrer A; Acampora E; Vasarri MV; Arienti F; Vergani P
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298762
[TBL] [Abstract][Full Text] [Related]
26. Does a sFlt-1/PlGF ratio result > 655 before 34 weeks' gestation necessitate preterm delivery within 2 days? A retrospective observational study.
Siepen C; Brennecke S
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2371047. PubMed ID: 38926094
[TBL] [Abstract][Full Text] [Related]
27. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Associations between Ambient Air Pollution and Angiogenic Biomarkers among Pregnant Women in the LIFECODES Study, 2006-2008.
Zheng Y; McElrath T; Cantonwine D; Hu H
Environ Health Perspect; 2023 Aug; 131(8):87005. PubMed ID: 37556304
[TBL] [Abstract][Full Text] [Related]
29. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
[TBL] [Abstract][Full Text] [Related]
30. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
31. Gestational Age-Specific Reference Ranges for the sFlt-1/PlGF Immunoassay Ratio in Twin Pregnancies.
De La Calle M; Delgado JL; Verlohren S; Escudero AI; Bartha JL; Campillos JM; Aguarón De La Cruz A; Chantraine F; García Hernández JÁ; Herraiz I; Llurba E; Kurka H; Guo G; Sillman J; Hund M; Perales Marín A
Fetal Diagn Ther; 2021; 48(4):288-296. PubMed ID: 33784677
[TBL] [Abstract][Full Text] [Related]
32. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
[TBL] [Abstract][Full Text] [Related]
33. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
Li J; Cai A; Yuan Q; Ding H; Zhao D
Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
[TBL] [Abstract][Full Text] [Related]
34. The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers.
Sundet BK; Kreyberg I; Staff AC; Carlsen KCL; Bains KES; Berg JP; Granum B; Haugen G; Hedlin G; Jonassen CM; Nordhagen LS; Nordlund B; Rehbinder EM; Rudi K; Rueegg CS; Sjøborg KD; Skjerven HO; Söderhäll C; Vettukattil R; Sugulle M
Biol Sex Differ; 2022 Jul; 13(1):39. PubMed ID: 35841068
[TBL] [Abstract][Full Text] [Related]
35. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Stepan H; Hund M; Dilba P; Sillman J; Schlembach D
Clin Chem Lab Med; 2019 Aug; 57(9):1339-1348. PubMed ID: 31323000
[TBL] [Abstract][Full Text] [Related]
36. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes.
Bednarek-Jędrzejek M; Kwiatkowski S; Ksel-Hryciów J; Tousty P; Nurek K; Kwiatkowska E; Cymbaluk-Płoska A; Torbé A
J Perinat Med; 2019 Sep; 47(7):732-740. PubMed ID: 31339858
[TBL] [Abstract][Full Text] [Related]
37. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
40. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
